Grant: Project Grant
McGill University
$619,650.00
Structural and mechanistic studies of PINK1, a mitochondrial ubiquitin kinase implicated in Parkinson's disease.
EF 2016-17
Résumé
Mutations in the Parkin and PINK1 genes cause juvenile familial forms of Parkinson's disease. These genes encode enzymes that degrade damaged components of the cells that are required to maintain neurons alive. However, how they accomplish these functions at the molecular level is unknown. The goal of this research project is to determine how PINK1 senses damage and enables Parkin to tag these damage components. The project will combine in an innovative way technologies such as mass spectrometry and X-ray crystallography to characterize and capture the interactions formed by these proteins. This knowledge will feed new experiments to shed light on the roles played by these enzymes, and will also guide the development of novel drugs that could cure Parkinson's disease.
Programme
Project Grant
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
358372
Name
Trempe Jean-François
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Project Grant Competition
Projecttitle
Structural and mechanistic studies of PINK1, a mitochondrial ubiquitin kinase implicated in Parkinson's disease.
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$619,650
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Mass Spectrometry; Mitochondria; Nmr; Parkin; Parkinson; Phosphorylation; Pink1; Ubiquitin; X-Ray Crystallography
Abstract
Mutations in the Parkin and PINK1 genes cause juvenile familial forms of Parkinson's disease. These genes encode enzymes that degrade damaged components of the cells that are required to maintain neurons alive. However, how they accomplish these functions at the molecular level is unknown. The goal of this research project is to determine how PINK1 senses damage and enables Parkin to tag these damage components. The project will combine in an innovative way technologies such as mass spectrometry and X-ray crystallography to characterize and capture the interactions formed by these proteins. This knowledge will feed new experiments to shed light on the roles played by these enzymes, and will also guide the development of novel drugs that could cure Parkinson's disease.
Competitiondate
201610
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Trempe, Jean-François
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $619,650~ $0~